Next Article in Journal
Chronic Exposure to Palmitate Impairs Insulin Signaling in an Intestinal L-cell Line: A Possible Shift from GLP-1 to Glucagon Production
Next Article in Special Issue
Electrochemical Detection of Dopamine at a Gold Electrode Modified with a Polypyrrole–Mesoporous Silica Molecular Sieves (MCM-48) Film
Previous Article in Journal
Differentially-Expressed miRNAs in Ectopic Stromal Cells Contribute to Endometriosis Development: The Plausible Role of miR-139-5p and miR-375
Previous Article in Special Issue
Uptake and Distribution of Fenoxanil-Loaded Mesoporous Silica Nanoparticles in Rice Plants
Open AccessArticle

Construction of a Glutathione-Responsive and Silica-Based Nanocomposite for Controlled Release of Chelator Dimercaptosuccinic Acid

1
College of Pharmacy, Institutes of Environment and Medicine, Henan University, Kaifeng 475004, China
2
Institute of Medicinal Biotechnology of Medical Science & Peking Union Medical College, Beijing 100850, China
3
State key laboratory of toxicology and medical countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Int. J. Mol. Sci. 2018, 19(12), 3790; https://doi.org/10.3390/ijms19123790
Received: 11 October 2018 / Revised: 24 November 2018 / Accepted: 25 November 2018 / Published: 28 November 2018
(This article belongs to the Special Issue Mesoporous Materials: From Synthesis to Applications)
Dimercaptosuccinic acid (DMSA) is an oral heavy metal chelator. Although DMSA is the most acceptable chelator in the urinary excretion of toxic elements from children and adults, its defects in plasma binding and the membrane permeability limit its interaction with intracellular elements and affect its efficacy in chelation therapy. Herein, a novel nanocomposite composed of mesoporous silica nanoparticles (MSNs), disulfide bond, and DMSA was synthesized and characterized with a scanning/transmission electron microscope, IR and Raman spectra, and TGA analysis. The in vitro interactions with glutathione (GSH) and cellular uptake assays showed that it was able to be stable in extracellular environments such as in blood, be internalized by cells, and release DMSA inside via GSH-triggered disulfide cleavage reaction. The in vitro adsorption assays showed that MSNs-SH as its intracellular metabolite had strong adsorbability for models of Hg2+ or Pb2+. The hemolysis and cell viability assays showed that it was compatible with blood and cells even at a concentration of 1000 μg·mL−1. All above could not only enable it to be a GSH-responsive drug delivery system (DDS) for DMSA delivery but also to be a solution for its defects and efficacy. Thus, introduction of intelligent DDS might open a new avenue for DMSA-based chelation therapy. View Full-Text
Keywords: mesoporous silica; disulfide bond; glutathione-responsive; controlled release; dimercaptosuccinic acid mesoporous silica; disulfide bond; glutathione-responsive; controlled release; dimercaptosuccinic acid
Show Figures

Figure 1

MDPI and ACS Style

Zhai, H.; Wang, Y.; Wang, M.; Liu, S.; Yu, F.; Gao, C.; Li, G.; Wu, Q. Construction of a Glutathione-Responsive and Silica-Based Nanocomposite for Controlled Release of Chelator Dimercaptosuccinic Acid. Int. J. Mol. Sci. 2018, 19, 3790.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop